Karl M Kilgore
5PUBLICATIONS
11CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Feb 24, 2026
Real-world outcomes after CAR T versus standard therapy in third-line or later relapsed or refractory follicular lymphoma in the United States.Philip K Chan, Markqayne Ray, Karl M Kilgore
|Oct 11, 2024
Impact of social determinants of health on hepatocellular carcinoma surveillance, treatment, and health care costs.Amit G Singal, Karl M Kilgore, Elizabet Shvets
|Apr 19, 2024
Race/ethnicity and socioeconomic position in emergency department utilization in patients with hepatocellular carcinoma.Daniel Lin, Ruoding Tan, Christie Teigland
|Jun 20, 2023
Real-world experience of CAR T-cell therapy in older patients with relapsed/refractory diffuse large B-cell lymphoma.Dai Chihara, Laura Liao, Joseph Tkacz
|Oct 14, 2021
Burden of illness and outcomes in second-line large B-cell lymphoma treatment: real-world analysis of Medicare beneficiaries.Karl M Kilgore, Iman Mohammadi, Anny C Wong
Pageof 1
Frequent Collaborators
1 joint publications
Anny C Wong
1 joint publications
Dai Chihara
1 joint publications
Loretta J Nastoupil
1 joint publications
Daniel Lin
1 joint publications
Neehar D Parikh
1 joint publications
Neil Mehta
1 joint publications
A Burak Ozbay
1 joint publications
Philip K Chan
1 joint publications
Markqayne Ray
1 joint publications
Christie Teigland
